Dr Santosh Indraksha, Deputy Drugs Controller (India), CDSCO, DGHS, MoH&FW, Government of India
FDD Conclave: Mumbai Connect | 6th March 2026
Author
India’s Pharma giants race to launch Semaglutide, intensifying GLP-1 market competition
India’s leading pharma companies have simultaneously forayed into the semaglutide segment, marking a major shift in the country’s…
BIRAC fuels innovation with Rs. 4,200 crore funding across 15 lakh startups and entrepreneurs
Biotechnology Industry Research Assistance Council (BIRAC), a Public Sector Enterprise set up by the Department of Biotechnology…
Lupin Manufacturing Solutions announces expansion of manufacturing facility at Dabhasa
Lupin Manufacturing Solutions (LMS), a global CRDMO and subsidiary of global pharma major Lupin Limited (Lupin), today announced a…
Eris launches weekly shot of Semaglutide starting at ₹220 per shot
Eris Lifesciences, a leading Indian branded formulations company, today announced a breakthrough step in expanding access to…
Glenmark Pharmaceuticals USA launches authorised generic to Milnacipran Hydrochloride tablets
Glenmark Pharmaceuticals USA announces the launch of Milnacipran Hydrochloride tablets, 12.5 mg, 25 mg, 50 mg, and 100 mg.…
Zydus launches Aerolife Mini, to simplify inhaler use for asthma and COPD patients
Zydus Lifesciences, an innovation-led life-sciences company with an international presence, has launched Aerolife Mini, a…
Partners in progress: PPL 2026
PPL 2026 brought together India’s pharma packaging ecosystem to explore how collaboration, innovation, and technical expertise can…
Akums launches first-of-its-kind Lasmiditan dispersible tablets for rapid migraine care
Akums Drugs & Pharmaceuticals has announced the launch of the world’s first Lasmiditan dispersible tablets, marking an…
Zydus and Torrent Pharma sign licensing agreement to co-market innovative Semaglutide injection in…
Zydus Lifesciences, an innovation-led global life-sciences company and Torrent Pharma, a specialty-focused global pharmaceutical…